Skip to content

Harrow HROW Valuation Allowances And Reserves Balance

Valuation Allowances And Reserves Balance at other companies

Bausch + Lomb logo
Bausch + LombBLCO
Bausch Health Companies logo
Bausch Health CompaniesBHC

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.8B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:ValuationAllowancesAndReservesBalance.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's valuation allowances and reserves balance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's valuation allowances and reserves balance?
Harrow (HROW) reported valuation allowances and reserves balance of $67.65M in Q1 2026.
How has Harrow's valuation allowances and reserves balance changed year-over-year?
Harrow's valuation allowances and reserves balance increased by 56.9% year-over-year, from $43.11M to $67.65M.
What is the long-term trend for Harrow's valuation allowances and reserves balance?
Over 3 years (2022 to 2025), Harrow's valuation allowances and reserves balance has grown at a 359.2% compound annual growth rate (CAGR), from $706K to $68.38M.